Growth evaluation of traditional Chinese medicine listed companies-by Topsis evaluation method based on factor analysis
10.7501/j.issn.0253-2670.2018.21.038
- VernacularTitle: 我国中药上市公司成长性评价研究——基于因子分析法的Topsis评价法
- Author:
Xue YANG
1
Author Information
1. College of Economics & Management, Huazhong Agricultural University
- Publication Type:Journal Article
- Keywords:
Comprehensive factor score;
Factor analysis;
Growth evaluation;
Optimal solution of closeness degree;
Topsis method;
Traditional Chinese medicine listed companies
- From:
Chinese Traditional and Herbal Drugs
2018;49(21):5220-5228
- CountryChina
- Language:Chinese
-
Abstract:
Using 54 traditional Chinese medicine (TCM) listed companies in China as a research sample, panel data of 54 companies from 2012 to 2016 was used, the 11 financial indicators was selected to build a Chinese medicine listed companies growth evaluation index system by the factor analysis method. On this basis, Topsis method was used to calculate the comprehensive factor of TCM listed companies and the optimal solution of the closeness degree, in order to analyze the growth of TCM listed companies. The results showed that about 79.63% of TCM listed companies’ comprehensive factor score and the optimal solution of the close degree near the distribution from 0.4 to 0.7, indicating that the growth of TCM listed companies have a greater room for improvement; Only 3.7% of TCM listed companies comprehensive factor score and the optimal solution near the distribution from 0.8 to 0.9. China's TCM listed companies did not play its leading role. Finally, this paper puts forward relevant policy suggestions for promoting the healthy development of TCM companies.
